National Toxicology Program (NTP); Office of Liaison, Policy and Review; Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM), 25754-25755 [E8-10010]
Download as PDF
<![CDATA[
25754
Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
An agenda and any additional
information for the meeting will be
posted on the agency’s Web site:
https://www.nih.gov/about/director/acd/
index.htm.
Background information may be
obtained by contacting NIH OBA by email oba@od.nih.gov
Dated: April 29, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8–10011 Filed 5–6–08; 8:45 am]
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–10013 Filed 5–6–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
National Cancer Institute; Notice of
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
sroberts on PROD1PC70 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
F—Manpower & Training; NCI–F Manpower
and Training Grants.
Date: May 19, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Lynn M. Amende, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8105,
Bethesda, MD 20892, 301–451–4759,
amendel@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
VerDate Aug<31>2005
21:00 May 06, 2008
Jkt 214001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the meeting of the
National Cancer Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Advisory Board.
Open: June 17, 2008, 8:30 a.m. to 3:20 p.m.
Agenda: Program reports and
presentations; Business of the Board.
Place: National Cancer Institute, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, MD 20892–8327, (301) 496–5147.
Name of Committee: National Cancer
Advisory Board.
Closed: June 17, 2008, 3:20 p.m. to 5 p.m.
Agenda: Review of grant applications.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, MD 20892–8327, (301) 496–5147.
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
Name of Committee: National Cancer
Advisory Board.
Open: June 18, 2008, 8:30 a.m. to 12 p.m.
Agenda: Program reports and
presentations; Business of the Board.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, MD 20892–8327, (301) 496–5147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page https://
deainfo.nci.nih.gov/advisory/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–10014 Filed 5–6–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Toxicology Program (NTP);
Office of Liaison, Policy and Review;
Meeting of the Scientific Advisory
Committee on Alternative
Toxicological Methods (SACATM)
National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH).
ACTION: *COM057*Meeting
announcement and request for
comment.
AGENCY:
SUMMARY: Pursuant to section 10(a) of
the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of
SACATM on June 18–19, 2008, at the
E:\FR\FM\07MYN1.SGM
07MYN1
Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices
Radisson Hotel Research Triangle Park,
150 Park Drive, Research Triangle Park,
NC 27709. The meeting is scheduled
from 8:30 a.m. to 5:30 p.m. on June 18
and 8:30 a.m. until adjournment on June
19. The meeting is open to the public
with attendance limited only by the
space available. SACATM advises the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM), the NTP Interagency Center
for the Evaluation of Alternative
Toxicological Methods (NICEATM), and
the Director of the NIEHS and NTP
regarding statutorily mandated duties of
ICCVAM and activities of NICEATM.
DATES: The SACATM meeting will be
held on June 18 and 19, 2008. All
individuals who plan to attend are
encouraged to register online at the NTP
Web site (https://ntp.niehs.nih.gov/go/
7441) by June 10, 2008. In order to
facilitate planning, persons wishing to
make an oral presentation are asked to
notify Dr. Lori White, NTP Executive
Secretary, via online registration, phone,
or email by June 10, 2008 (see
ADDRESSES below). Written comments
should also be received by June 10 to
enable review by SACATM and NIEHS/
NTP staff before the meeting.
ADDRESSES: The SACATM meeting will
be held at the Radisson Hotel Research
Triangle Park, 150 Park Drive, Research
Triangle Park, NC 27709 [hotel: (919)
549–8631]. Public comments and other
correspondence should be directed to
Dr. Lori White (NTP Office of Liaison,
Policy and Review, NIEHS, P.O. Box
12233, MD A3–01, Research Triangle
Park, NC 27709; telephone: 919–541–
9834 or e-mail: whiteld@niehs.nih.gov).
Courier address: NIEHS, 111 T.W.
Alexander Drive, Room A326, Research
Triangle Park, NC 27709. Persons
needing interpreting services in order to
attend should contact 301–402–8180
(voice) or 301–435–1908 (TTY).
Requests should be made at least 7 days
in advance of the meeting.
SUPPLEMENTARY INFORMATION:
sroberts on PROD1PC70 with NOTICES
Preliminary Agenda Topics and
Availability of Meeting Materials
Preliminary agenda topics include:
• NICEATM–ICCVAM Update;
• Overview of NICEATM–ICCVAM
5–Year Plan;
• NRC Report: Toxicity Testing in the
21st Century;
• Presentations from Federal
Agencies on Research, Development,
Translation, and Validation Activities
Relevant to the NICEATM–ICCVAM
Five-Year Plan;
• Report on the ICCVAM–NICEATM
Independent Scientific Peer Review
Meeting: Validation Status of New
VerDate Aug<31>2005
21:00 May 06, 2008
Jkt 214001
Versions and Applications of the
Murine Local Lymph Node Assay
(LLNA), a Test Method for Assessing the
Contact Dermatitis Potential of
Chemicals and Products;
• Report on the ICCVAM–NICEATM–
ECVAM–JACVAM Scientific Workshop
on Acute Chemical Safety Testing:
Advancing In Vitro Approaches and
Humane Endpoints for Systemic
Toxicity Evaluations;
• Nominations to ICCVAM: NTP
Rodent Bioassay for Carcinogenicity;
• Proposal for International
Cooperation on Alternative Test
Methods;
• Update from the Japanese Center for
the Validation of Alternative Methods;
• Update from the European Center
for the Evaluation of Alternative
Methods,
A copy of the preliminary agenda,
committee roster, and additional
information, when available will be
posted on the NTP Web site (https://
ntp.niehs.nih.gov/go/7441) or available
upon request (see ADDRESSES above).
Following the SACATM meeting,
summary minutes will be prepared and
available on the NTP website or upon
request.
Request for Comments
Both written and oral public input on
the agenda topics is invited. Written
comments received in response to this
notice will be posted on the NTP Web
site. Persons submitting written
comments should include their name,
affiliation (if applicable), and
sponsoring organization (if any) with
the document. Time is allotted during
the meeting for presentation of oral
comments and each organization is
allowed one time slot per public
comment period. At least 7 minutes will
be allotted for each speaker, and if time
permits, may be extended up to 10
minutes at the discretion of the chair.
Registration for oral comments will also
be available on-site, although time
allowed for presentation by on-site
registrants may be less than for preregistered speakers and will be
determined by the number of persons
who register at the meeting.
Persons registering to make oral
comments are asked to do so through
the online registration form (https://
ntp.niehs.nih.gov/go/7441) and to send
a copy of their statement to Dr. White
(see ADDRESSES above) by June 10 to
enable review by SACATM, NICEATM–
ICCVAM, and NIEHS/NTP staff prior to
the meeting. Written statements can
supplement and may expand the oral
presentation. If registering on-site and
reading from written text, please bring
40 copies of the statement for
PO 00000
Frm 00115
Fmt 4703
Sfmt 4703
25755
distribution and to supplement the
record.
Background Information on ICCVAM,
NICEATM, and SACATM
ICCVAM is an interagency committee
composed of representatives from 15
Federal regulatory and research agencies
that use, generate, or disseminate
toxicological information. ICCVAM
conducts technical evaluations of new,
revised, and alternative methods with
regulatory applicability and promotes
the development, scientific validation,
regulatory acceptance, implementation,
and national and international
harmonization of new, revised, and
alternative toxicological test methods
that more accurately assess the safety
and hazards of chemicals and products
and that refine, reduce, and replace
animal use. The ICCVAM Authorization
Act of 2000 [42 U.S.C. 285l–3]
established ICCVAM as a permanent
interagency committee of the NIEHS
under NICEATM. NICEATM
administers ICCVAM and provides
scientific and operational support for
ICCVAM-related activities. NICEATM
and ICCVAM work collaboratively to
evaluate new and improved test
methods applicable to the needs of U.S.
Federal agencies. Additional
information about ICCVAM and
NICEATM can be found on their Web
site (https://iccvam.niehs.nih.gov).
SACATM was established in response
to the ICCVAM Authorization Act
[Section 285l–3(d)] and is composed of
scientists from the public and private
sectors. SACATM advises ICCVAM,
NICEATM, and the Director of the
NIEHS and NTP regarding statutorily
mandated duties of ICCVAM and
activities of NICEATM. SACATM
provides advice on priorities and
activities related to the development,
validation, scientific review, regulatory
acceptance, implementation, and
national and international
harmonization of new, revised, and
alternative toxicological test methods.
Additional information about SACATM,
including the charter, roster, and
records of past meetings, can be found
at https://ntp.niehs.nih.gov/go/167.
Dated: April 28, 2008.
Samuel H. Wilson,
Acting Director, National Institute of
Environmental Health Sciences and National
Toxicology Program.
[FR Doc. E8–10010 Filed 5–6–08; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 73, Number 89 (Wednesday, May 7, 2008)]
[Notices]
[Pages 25754-25755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10010]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Toxicology Program (NTP); Office of Liaison, Policy and
Review; Meeting of the Scientific Advisory Committee on Alternative
Toxicological Methods (SACATM)
AGENCY: National Institute of Environmental Health Sciences (NIEHS),
National Institutes of Health (NIH).
ACTION: *COM057*Meeting announcement and request for comment.
-----------------------------------------------------------------------
SUMMARY: Pursuant to section 10(a) of the Federal Advisory Committee
Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a
meeting of SACATM on June 18-19, 2008, at the
[[Page 25755]]
Radisson Hotel Research Triangle Park, 150 Park Drive, Research
Triangle Park, NC 27709. The meeting is scheduled from 8:30 a.m. to
5:30 p.m. on June 18 and 8:30 a.m. until adjournment on June 19. The
meeting is open to the public with attendance limited only by the space
available. SACATM advises the Interagency Coordinating Committee on the
Validation of Alternative Methods (ICCVAM), the NTP Interagency Center
for the Evaluation of Alternative Toxicological Methods (NICEATM), and
the Director of the NIEHS and NTP regarding statutorily mandated duties
of ICCVAM and activities of NICEATM.
DATES: The SACATM meeting will be held on June 18 and 19, 2008. All
individuals who plan to attend are encouraged to register online at the
NTP Web site (https://ntp.niehs.nih.gov/go/7441) by June 10, 2008. In
order to facilitate planning, persons wishing to make an oral
presentation are asked to notify Dr. Lori White, NTP Executive
Secretary, via online registration, phone, or email by June 10, 2008
(see ADDRESSES below). Written comments should also be received by June
10 to enable review by SACATM and NIEHS/NTP staff before the meeting.
ADDRESSES: The SACATM meeting will be held at the Radisson Hotel
Research Triangle Park, 150 Park Drive, Research Triangle Park, NC
27709 [hotel: (919) 549-8631]. Public comments and other correspondence
should be directed to Dr. Lori White (NTP Office of Liaison, Policy and
Review, NIEHS, P.O. Box 12233, MD A3-01, Research Triangle Park, NC
27709; telephone: 919-541-9834 or e-mail: whiteld@niehs.nih.gov).
Courier address: NIEHS, 111 T.W. Alexander Drive, Room A326, Research
Triangle Park, NC 27709. Persons needing interpreting services in order
to attend should contact 301-402-8180 (voice) or 301-435-1908 (TTY).
Requests should be made at least 7 days in advance of the meeting.
SUPPLEMENTARY INFORMATION:
Preliminary Agenda Topics and Availability of Meeting Materials
Preliminary agenda topics include:
NICEATM-ICCVAM Update;
Overview of NICEATM-ICCVAM 5-Year Plan;
NRC Report: Toxicity Testing in the 21st Century;
Presentations from Federal Agencies on Research,
Development, Translation, and Validation Activities Relevant to the
NICEATM-ICCVAM Five-Year Plan;
Report on the ICCVAM-NICEATM Independent Scientific Peer
Review Meeting: Validation Status of New Versions and Applications of
the Murine Local Lymph Node Assay (LLNA), a Test Method for Assessing
the Contact Dermatitis Potential of Chemicals and Products;
Report on the ICCVAM-NICEATM-ECVAM-JACVAM Scientific
Workshop on Acute Chemical Safety Testing: Advancing In Vitro
Approaches and Humane Endpoints for Systemic Toxicity Evaluations;
Nominations to ICCVAM: NTP Rodent Bioassay for
Carcinogenicity;
Proposal for International Cooperation on Alternative Test
Methods;
Update from the Japanese Center for the Validation of
Alternative Methods;
Update from the European Center for the Evaluation of
Alternative Methods,
A copy of the preliminary agenda, committee roster, and additional
information, when available will be posted on the NTP Web site (https://
ntp.niehs.nih.gov/go/7441) or available upon request (see ADDRESSES
above). Following the SACATM meeting, summary minutes will be prepared
and available on the NTP website or upon request.
Request for Comments
Both written and oral public input on the agenda topics is invited.
Written comments received in response to this notice will be posted on
the NTP Web site. Persons submitting written comments should include
their name, affiliation (if applicable), and sponsoring organization
(if any) with the document. Time is allotted during the meeting for
presentation of oral comments and each organization is allowed one time
slot per public comment period. At least 7 minutes will be allotted for
each speaker, and if time permits, may be extended up to 10 minutes at
the discretion of the chair. Registration for oral comments will also
be available on-site, although time allowed for presentation by on-site
registrants may be less than for pre-registered speakers and will be
determined by the number of persons who register at the meeting.
Persons registering to make oral comments are asked to do so
through the online registration form (https://ntp.niehs.nih.gov/go/7441)
and to send a copy of their statement to Dr. White (see ADDRESSES
above) by June 10 to enable review by SACATM, NICEATM-ICCVAM, and
NIEHS/NTP staff prior to the meeting. Written statements can supplement
and may expand the oral presentation. If registering on-site and
reading from written text, please bring 40 copies of the statement for
distribution and to supplement the record.
Background Information on ICCVAM, NICEATM, and SACATM
ICCVAM is an interagency committee composed of representatives from
15 Federal regulatory and research agencies that use, generate, or
disseminate toxicological information. ICCVAM conducts technical
evaluations of new, revised, and alternative methods with regulatory
applicability and promotes the development, scientific validation,
regulatory acceptance, implementation, and national and international
harmonization of new, revised, and alternative toxicological test
methods that more accurately assess the safety and hazards of chemicals
and products and that refine, reduce, and replace animal use. The
ICCVAM Authorization Act of 2000 [42 U.S.C. 285l-3] established ICCVAM
as a permanent interagency committee of the NIEHS under NICEATM.
NICEATM administers ICCVAM and provides scientific and operational
support for ICCVAM-related activities. NICEATM and ICCVAM work
collaboratively to evaluate new and improved test methods applicable to
the needs of U.S. Federal agencies. Additional information about ICCVAM
and NICEATM can be found on their Web site (https://
iccvam.niehs.nih.gov).
SACATM was established in response to the ICCVAM Authorization Act
[Section 285l-3(d)] and is composed of scientists from the public and
private sectors. SACATM advises ICCVAM, NICEATM, and the Director of
the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and
activities of NICEATM. SACATM provides advice on priorities and
activities related to the development, validation, scientific review,
regulatory acceptance, implementation, and national and international
harmonization of new, revised, and alternative toxicological test
methods. Additional information about SACATM, including the charter,
roster, and records of past meetings, can be found at https://
ntp.niehs.nih.gov/go/167.
Dated: April 28, 2008.
Samuel H. Wilson,
Acting Director, National Institute of Environmental Health Sciences
and National Toxicology Program.
[FR Doc. E8-10010 Filed 5-6-08; 8:45 am]
BILLING CODE 4140-01-P
